Harlan Krumholz
See the following -
In Stunning Win For Open Science, Johnson & Johnson Decides To Release Its Clinical Trial Data To Researchers
Drug companies tend to be secretive, to say the least, about studies of their medicines. For years, negative trials would not even be published. Except for the U.S. Food and Drug Administration, nobody got to look at the raw information behind those studies. The medical data behind important drugs, devices, and other products was kept shrouded. Read More »
- Login to post comments
In Stunning Win For Open Science, Johnson & Johnson Decides To Release Its Clinical Trial Data To Researchers
Today, Johnson & Johnson JNJ +0.07% is taking a major step toward changing that, not only for drugs like the blood thinner Xarelto or prostate cancer pill Zytiga but also for the artificial hips and knees made for its orthopedics division or even consumer products. “You want to know about Listerine trials? They’ll have it,” says Harlan Krumholz of Yale University, who is overseeing the group that will release the data to researchers.
- Login to post comments
J&J Sets Drug Data Free In ‘YODA’ Collaboration With Yale
Johnson & Johnson (JNJ) will give academics access to data on clinical trials, a move that may prompt more companies to do the same. Read More »
- Login to post comments
Yale Program's Agreement With Johnson & Johnson Allows Broad Access To Clinical Trial Data
In a move that promotes open science, the Yale University Open Data Access (YODA) Project has entered an agreement with Johnson & Johnson that will enable scientists around the world to gain access to the company's clinical trial data assets. Read More »
- Login to post comments
Yale Program’s Agreement With Johnson & Johnson Allows Broad Access To Clinical Trial Data
In a move that promotes open science, the Yale University Open Data Access (YODA) Project has entered an agreement with Johnson & Johnson that will enable scientists around the world to gain access to the company’s clinical trial data assets. Read More »
- Login to post comments